Literature DB >> 16226007

Epigenetic regulation of Th1 and Th2 cell development.

Virginia M Sanders1.   

Abstract

All cells of the body, regardless of the tissue type, contain the same genetic material, but express this genetic material differently. Epigenetics is one process by which differential gene expression within a cell is regulated. Epigenetic mechanisms involve postsynthetic modifications to DNA and/or DNA-associated histones that do not change the DNA sequence itself, but which remodel chromatin, are passed along at each cell division, and occur during and after early development. The CD4+ T cell best represents a cell in which epigenetic mechanisms are used to affect mature cell physiology. As a naïve CD4+ T cell develops into either a Th1 or Th2 cell that secretes predominantly IFN-gamma or IL-4, respectively, the expression of one cytokine gene and the permanent silencing of the other is orchestrated using epigenetic mechanisms. Because there appears to be an association between Th1/Th2 cell immunity, behavior, and/or disease, it is possible that an environmentally induced epigenetic change that occurs during Th1/Th2 cell development could explain how certain Th1/Th2-associated conditions develop. This article will review basic epigenetic mechanisms and what is known about how these mechanisms influence cytokine gene expression in a naïve CD4+ T cell as it develops into a Th1 or Th2 cell.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16226007     DOI: 10.1016/j.bbi.2005.08.005

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  23 in total

1.  Fetal epigenetic mechanisms and innate immunity in asthma.

Authors:  Petra Ina Pfefferle; Olaf Pinkenburg; Harald Renz
Journal:  Curr Allergy Asthma Rep       Date:  2010-11       Impact factor: 4.806

Review 2.  Regulation of CD4 T-cell differentiation and inflammation by repressive histone methylation.

Authors:  Frann Antignano; Colby Zaph
Journal:  Immunol Cell Biol       Date:  2015-01-13       Impact factor: 5.126

3.  Epigenetic manipulation restores functions of defective CD8⁺ T cells from chronic viral infection.

Authors:  Fuqin Zhang; Xiaohui Zhou; Joanna R DiSpirito; Chuan Wang; Ying Wang; Hao Shen
Journal:  Mol Ther       Date:  2014-05-27       Impact factor: 11.454

Review 4.  Developmental origins of inflammatory and immune diseases.

Authors:  Ting Chen; Han-Xiao Liu; Hui-Yi Yan; Dong-Mei Wu; Jie Ping
Journal:  Mol Hum Reprod       Date:  2016-05-25       Impact factor: 4.025

5.  Hypermethylation of IFN-γ in oral cancer tissues.

Authors:  Songbo Tian; Chunyang Jiang; Xiaoqin Liu; Sheng Xu; Zhiyong Zhang; Huizhen Chen; Yinghuai Zhang; Yanping Liu; Dong Ma
Journal:  Clin Oral Investig       Date:  2017-01-13       Impact factor: 3.573

Review 6.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 7.  Epigenetics and periodontal disease: future perspectives.

Authors:  Ricardo Santiago Gomez; Walderez Ornelas Dutra; Paula Rocha Moreira
Journal:  Inflamm Res       Date:  2009-05-08       Impact factor: 4.575

8.  Nasal epithelial cells as surrogates for bronchial epithelial cells in airway inflammation studies.

Authors:  Catherine M McDougall; Morgan G Blaylock; J Graham Douglas; Richard J Brooker; Peter J Helms; Garry M Walsh
Journal:  Am J Respir Cell Mol Biol       Date:  2008-05-15       Impact factor: 6.914

9.  Single nucleotide polymorphism in DNMT3B promoter and the risk for idiopathic thrombocytopenic purpura in Chinese population.

Authors:  Zhenping Chen; Zeping Zhou; Xiaoli Chen; Jianhui Xu; Aijuan Liu; Weiting Du; Dongsheng Gu; Jing Ge; Zhenxing Guo; Xiaoyan Wang; Xunwei Dong; Qian Ren; Renchi Yang
Journal:  J Clin Immunol       Date:  2008-04-25       Impact factor: 8.317

10.  DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors.

Authors:  Ying Liu; Rork Kuick; Samir Hanash; Bruce Richardson
Journal:  Clin Immunol       Date:  2008-10-22       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.